Pulmonary embolism (PE) remains a common and potentially life-threatening cardiovascular emergency. Systemic thrombolysis with intravenous infusion of a thrombolytic agent is generally recommended for treatment of high risk PE. However, this method has known limitations in the presence of high bleeding risk. Catheter-directed thrombolysis has the potential to achieve the same benefits as systemic thrombolysis, with a lower risk of haemorrhage.
InTROduCTIOn
Acute pulmonary embolism (PE) is a life-threatening condition which has an estimated global mortality rate of 15% at 3 months. 1 High risk pulmonary embolism is defined as an acute PE associated with persistent systemic arterial hypotension, a systolic arterial pressure <90 mmHg, the requirement of an inotropic agent, cardiogenic shock, or a condition progressing to the need for cardiopulmonary resuscitation. In severe cases of high risk PE, the in-hospital mortality rate may exceed 50%. 2 Systemic thrombolysis with intravenous infusion of a thrombolytic agent is generally recommended for treatment of high risk PE. However a meta-analysis of randomized clinical trials of thrombolytic treatment versus heparin-only treatment, demonstrated no significant reduction in death rates due to an increase in the number of haemorrhagic events. [3] [4] [5] The case presented is of a 67-year-old male patient having a high risk of pulmonary embolism and contraindications for systemic thrombolysis, in whom the presence of severe comorbidities led to an increased risk of surgical embolectomy, who was successfully treated by catheter-directed thrombolysis.
CASE PRESEnTATIOn
A 67-year-old man presented to the emergency department with severe shortness of breath which had commenced abruptly the day before admission, followed by collapse without loss of consciousness. Associated symptoms were chest pain and diaphoresis. He had no known drug allergies.
His vital signs showed a systolic blood pressure of 90/60 mmHg, a heart rate of 134 beats per minute, a respiratory rate of 37 per minute with an oxygen saturation of 80% when breathing air and 91% when using a 100%
non-rebreather facemask. He was pale, diaphoretic, and his jugular veins were distended to the angle of the jaw. ng/ml, reference range <0.02 ng/ml) and NTproBNP (974 pg/ml, reference range <400 pg/ml), mild anemia (Htc 11.6 g%, Htc 36.1%) with slightly elevated liver enzymes Table 1 ).
The patient was immediately given a saline infusion and a loading dose of 5000 IU intravenous heparin for a suspected pulmonary embolism. The patient's blood pressure continued to decrease, therefore a dopamine infusion was initiated at a rate of 7.5 micrograms/kg/ minute.
The computed tomogram (CT) showed a large filling defect at the bifurcation of the main pulmonary artery with a diameter of 11 mm, and two filling defects at the origin of the right pulmonary artery and left pulmonary artery, havixng dimensions of 26 × 22 mm and 17 × 14 mm respectively, as well as multiple sub-segmental clots (Figures 2A and B) . The native head CT was negative for intracranial bleeding (Figure 3 ). Considering the haemodynamic compromise resulting from the massive pulmonary embolism, and the high risk of intracranial bleeding due to the neurosurgical medical history, the local heart team decided to take an interventional approach for the treatment of this complicated case.
Pulmonary angiogram was performed using a Judkins Left 4.0 guiding coronary catheter introduced via the femoral vein. On reaching the right atrium, the catheter passed into the left atrium without any resistance, through a previously unidentified atrial septal defect.
After being injected into the right atrium, contrast media passed from the right atrium to the left heart and the aorta (Figure 4 ). After insertion of the catheter into the main pulmonary artery, the pulmonary angiogram confirmed the presence of massive emboli in the pulmonary circulation ( Figure 5 ).
Knowing the fact that the administration of rtPA is associated with a higher incidence of intracranial bleeding, streptokinase (SK) was given in a half dose of 125.000 IU over thirty minutes, followed by 50.000 IU/h for twelve hours. Following the infusion of thrombolytic therapy, the patient's blood pressure increased to 115/80 mmHg, at which point the administration of dopamine was discontinued. The tachycardia decreased to 85/min, shortness of breath diminished, and oxygen saturation was >94% on breathing air. Post-thrombolysis ECG showed sinus 
dISCuSSIOnS
Heparin is considered the cornerstone of management of PE, accelerating the action of antithrombin III, preventing additional thrombus formation and allowing endogenous fibrinolysis to dissolve a significant part of a clot. reporting on a total of 594 patients with high risk PE, showed an 87% clinical success with stabilization of haemodynamic parameters, hypoxia reduction and survival up to the point of discharge. 7 The effect of the low-dose catheter-directed thrombolysis on recovery of right ventricular function appears comparable to the one obtained using standard-dose systemic thrombolysis, with a lower risk of intracranial or any kind of life-threatening bleeding.
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The current case is remarkable due to the presence of a massive PE in association with contraindications for systemic thrombolysis and severe comorbidities, which led to an inacceptable high risk for surgical embolectomy. In cases when alteplase administraion is contraindicated or there is insufficient time for full-dose administration, catheter-directed thrombolysis may be the only practicable treatment option. In experienced centers, the use of modern catheter-directed thrombolitic therapy has proven to be a life-saving treatment in patients dying from acute massive PE. 
COnCLuSIOnS
Pulmonary embolism is a potentially life-threatening cardiovascular emergency associated with significant morbidity and mortality both in the early and late stages.
In patients presenting with high risk PE and associated severe comorbidities which lead to an increased risk of major bleeding, catheter-directed thrombolysis represents a feasible alternative strategy to surgical embolectomy. Patients treated with selective thrombolytic therapy show rapid improvement of right ventricular function and pulmonary perfusion which may lead to a lowering of early recurrent PE and decreased risk of developing late sequelae such as chronic pulmonary hypertension.
